GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (FRA:QL1A) » Definitions » Float Percentage Of Total Shares Outstanding

QuidelOrtho (FRA:QL1A) Float Percentage Of Total Shares Outstanding : 68.22% (As of May. 31, 2024)


View and export this data going back to 2005. Start your Free Trial

What is QuidelOrtho Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, QuidelOrtho's float shares is 45.68 Mil. QuidelOrtho's total shares outstanding is 66.97 Mil. QuidelOrtho's float percentage of total shares outstanding is 68.22%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, QuidelOrtho's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, QuidelOrtho's Institutional Ownership is 84.76%.


QuidelOrtho Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

QuidelOrtho's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=45.68/66.97
=68.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QuidelOrtho (FRA:QL1A) Business Description

Industry
Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho (FRA:QL1A) Headlines

No Headlines